| BioPharm Business & Technical Strategy Alignment "What I really appreciated from ResultWorks was the broad perspective that they brought to the table that gave us a better sense of how technical strategies can be devised and how we look at and organize them." - Director BioPharm Technologies ResultWorks Orchestrates CTMS Definition and Vendor Selection "ResultWorks' approach forced us to identify the best product to support our business process and is a model for future projects of this nature." - Assistant Director of IT Data Management Strategy Roadmap "IMPRESSIVE!" - Business IT Leader for Pharmaceutical Sciences Data Quality Assessment for Pharmaceutical Development "This is exactly what the business needed! We have several other areas that could use this same type of analysis." - Director of Data Services Architecting Clinical Sample Management A significant percentage of identified improvements were process optimizations which the business was able to undertake immediately. Formulations Electronic Lab Notebook Evaluation Rapid selection and piloting of a commercial ELN solution met the global business and technical needs. Change Management and Model Based Drug Development A diagnose and design approach led to a comprehensive implementation plan to manage the rollout of the new MBDD approach to pilot teams first and then to full scale production. Knowledge Roadmap Enabled the client to rapidly assess their knowledge landscape and to shape their IT strategy accordingly. Discovery PK Process Assessment and Strategy Roadmap "This project is a prototype of the approach needed as we look at other areas of R&D." - Assistant VP of IT Global ELN Pilot Implementation “Researchers are already more productive getting experiments performed.” - Site Head Discovery Chemistry Knowledge Assessment “The process models and information asset documentation has been very well received by R&D and is actively being used to inform our knowledge management strategy and supporting informatics projects.” - Functional IT Lead Global Electronic Lab Notebook Evaluation “You guys are really good at what you do! Your understanding of the project and of our company were excellent. I was initially dubious about using consultants, but I now feel that we got our money’s worth.” - Result SessionSM Participant Global LIMS Strategy Transformation The strategy of common systems,data and access within functional groups is leading to better workflow, resource management, and decision-making. Global Business Process Harmonization "Of all the efforts we undertook this year, this is the only one that delivered what and when we promised." - Pharmacokinetic Research Systems Project Manager Clinical Study Process Assessment "ResultWorks recommendations are part of our strategic plan for the upcoming year." - VP of Clinical Pharmacology Clinical PK Solution Implmentation "The ResultWorks Project Manager did an amazing job of managing everything and keeping the project moving forward." - Manager of Informatics Pre-Clinical Toxicology Analysis & Reporting Process Streamlined "Study report creation improved from two weeks to less than two hours." - Research Manager Improved Data Visualization Tools Strategy For Discovery Scientists "I have heard from a number of people that the Result Session was an unqualified success. Both scientists and informatics people commented that it was the best prepared information management interaction they have had.... The outcomes I expected appear to have been met and exceeded." - VP Global Informatics Global Chemical Ordering System Evaluation "Everything I've heard indicates that this was a great engagement and you did a fantastic job. Many thanks for that. You've restored my faith in the use of external consultants for this sort of work." - Director of Discovery IT Global Computer Systems Validation Strategy for Research The global computer systems validation process now supports global system implementations. LIMS Lessons Learned Assessment "This was very useful. The discussion of issues allowed us to identify and commit to a path forward. We are putting the necessary attention against it now." - VP of Clinical Pharmacology |